Viridium Pacific Group (CVE:VIR) Shares Up 5.6% – Should You Buy?

Viridium Pacific Group Ltd (CVE:VIR – Get Free Report)’s share price was up 5.6% on Wednesday. The stock traded as high as C$0.41 and last traded at C$0.38. Approximately 26,500 shares traded hands during trading, a decline of 71% from the average session volume of 92,632 shares. The stock had previously closed at C$0.36.

Viridium Pacific Group Stock Up 5.6%

The firm has a market cap of C$37.52 million and a P/E ratio of -2.97. The business has a fifty day moving average of C$0.38 and a 200 day moving average of C$0.38.

About Viridium Pacific Group

(Get Free Report)

Viridium Pacific Group Ltd., through its subsidiaries, engages in the production, possession, and selling of medical cannabis in Canada. It is also involved in the contract manufacturing of cannabis oil capsules. The company provides its products for adult use, and wellness and therapeutic daily use. Viridium Pacific Group Ltd. is headquartered in Mission, Canada.

Read More

Receive News & Ratings for Viridium Pacific Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viridium Pacific Group and related companies with MarketBeat.com's FREE daily email newsletter.